Skip to content
The Nexus
DossierENTITY

65+ age group

Coverage of 65+ age group in the Nexus archive.

Earliest in view: Jun 3 · 02:54 UTCMost recent: Jun 18 · 20:11 UTC
Co-mentioned in this coverage
FDAorganization1Modernaorganization1mFlusivatopic1mRNA technologytopic1Influenzatopic1Dr. Flor Munoz-Rivasperson1Dr. Anna Durbinperson1Dr. Rituparna Dasperson1Dr. Timothy Brennanperson150-64 age grouptopic1San Franciscoplace1rowhouse firestopic1
Recent coverage
  • HEALTHJun 18 · 20:11 UTCWPLG LOCAL 10 MIAMI
    FDA panel backs first-of-its-kind flu vaccine using mRNA technology

    An FDA panel recommended approval of Moderna's first mRNA-based flu vaccine, mFlusiva, for adults aged 50 and older, citing its benefits outweighing risks. The vaccine, developed using technology similar to COVID-19 vaccines, showed a 27% reduction in flu cases compared to traditional vaccines in clinical trials and is under final FDA review for potential approval by August.

  • POLITICSJun 3 · 02:54 UTCMISSION LOCAL SF
    San Francisco polls close: Will tonight’s big winner be rowhouse fires?

    San Francisco polls have closed, with 44% of early voters being residents aged 65 or older. The article questions whether this demographic will be the main winner in the current election.

65+ age group · Dossier · The Nexus